Article
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
2024-01-05
Abstract excerpt
Gremlin-1 has been implicated in liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH) via inhibition of bone-morphogenetic protein (BMP) signalling and has thereby been identified as a potential therapeutic target. Using rat in vivo and human in vitro and ex vivo model systems of MASH fibrosis, we show that neutralisation of Gremlin-1 activity with monoclonal therapeutic antibodies does not...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 95d7bb96-78c1-5c4c-b41f-cb969a7d308f
- DOI
- 10.1101/2024.01.03.574043
